Navigation Links
Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations
Date:8/27/2009

potential, decreasing exacerbations and improving lung function. The uniformity of the results is really encouraging and gives us great hope that our faith in roflumilast has been confirmed. We are now undergoing the regulatory review process with the European and US authorities."

"Based on the results from the pivotal studies published this week, it appears that roflumilast provides added activity on top of other commonly used treatments for COPD," said Lawrence S. Olanoff, President and Chief Operating Officer of Forest Laboratories. "Roflumilast represents the first in a new class of agents to treat COPD and, if approved, would be the first oral anti-inflammatory maintenance treatment for the disease."

About Roflumilast (Daxas(R))

Roflumilast( )is an orally administered phosphodiesterase 4 (PDE4) enzyme inhibitor targeting cells and mediators in the body believed to be important in the COPD disease process. Roflumilast is expected to act on the underlying mechanism of COPD and related inflammatory diseases. If approved, roflumilast, a once-a-day oral tablet, will be the first in an entirely new class of treatment for COPD. It will also be the first oral anti-inflammatory treatment for COPD patients. Current treatment for COPD patients includes the use of inhaled bronchodilators and inhaled corticosteroids.

About COPD

COPD is an under-diagnosed progressive lung disease that may lead to death. Worldwide, COPD kills four people every minute and the World Health Organization (WHO) predicts that it will be the third leading cause of death by 2030. WHO estimates that 80 million people have moderate to severe COPD.

Symptoms of COPD include breathlessness, chronic cough and excessive production of phlegm. A significant worsening of symptoms called an exacerbation or lung attack can last several weeks. Breathing becomes severely compromised and patients may need to be admitted to
'/>"/>

SOURCE Nycomed
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
2. Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss
3. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
4. PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies
5. Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies
6. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
7. School of Dentistry Studies Link Between Oral Health and Memory
8. Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells
9. New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
10. Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)
11. Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "China Orthopedic Instrument Industry Report, 2014-2017" ... accelerated aging population and rising proportion of reimbursement for ... been effectively released, with its scale presenting a CAGR ... joint products are three product segments of orthopedic instruments ...
(Date:8/29/2014)... , August 29, 2014 ... Oil Market by Extraction type (SFE, Cold Pressed, ... Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - ... MarketsandMarkets, defines and segments the Amaranth Seed Oil ... market size in terms of value. The Amaranth ...
(Date:8/29/2014)... SPRING, Md. , Aug. 29, 2014  United ... that the U.S. District Court for the District of ... its favor in the company,s case against Sandoz, Inc. ... Judge Peter Sheridan ruled that U.S. Patent ... Inc., and enjoined Sandoz from marketing its generic product ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4District Court Decision Received In Remodulin Patent Case 2
... EyeScience(TM) ( www.eyescience.com ) announced today that ... and Dry Eye Formula(TM) are the only ... from their offices and through mass market retail. This announcement ... growing demand for the most complete eye vitamins available for ...
... (Nasdaq: HOLX ) today announced that Jack Cumming, Chairman, ... London on Tuesday, December 1, 2009, at 11:15am (GMT). ... audio webcast of Hologic,s investor presentation on the investor section ... An archive of the presentation will be available for replay ...
Cached Medicine Technology:EyeScience(TM) Announces New Program to Improve Patient Compliance and Practice Profits 2EyeScience(TM) Announces New Program to Improve Patient Compliance and Practice Profits 3
(Date:9/2/2014)... (PRWEB) September 02, 2014 Michigan’s health ... Affordable Care Act and the Healthy Michigan Plan. Throughout ... Komen remains a trusted funding resource for under-served individuals. ... assist uninsured or underinsured women between the ages of ... below 250 percent of the federal poverty level. ...
(Date:9/2/2014)... Plano, Texas (PRWEB) September 02, 2014 ... Expo, Prosupps will be an exhibitor at ... 3150 Paradise Rd, Las Vegas, NV 89109 Booth #374 ... vision is to encourage healthy living through exercise, diet ... to this vision, and provide the tools for all ...
(Date:9/2/2014)... Barcelona, Spain Tuesday 2 September 2014: Health ... heart failure guidelines, according to the results of ... Congress by Professor Aldo Maggioni. Clinical variables explained ... said: "This is a unique evaluation which combines ... countries. It provides a fuller picture of the ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Attorney Robert ... the 2015 "Lawyer of the Year" for Medical Malpractice ... & Meyer PC, Boston, and has been selected for inclusion ... Only one lawyer in each practice area and designated metropolitan ... on particularly impressive voting averages received during the peer-review assessments. ...
(Date:9/2/2014)... BC (PRWEB) September 02, 2014 ... pioneer in Canada announced today the expansion of its ... the company’s first Chief Financial Officer. Liang joins AURO ... Web Hosting, and will work closely with the operations, ... on expanding their cloud presence as well as ensuring ...
Breaking Medicine News(10 mins):Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 2Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 3Health News:Prosupps, One of the Fastest Growing Supplement Companies, Celebrates a Success Milestone with Exhibiting at the 50th Annual 2014 Mr. Olympia’s Fitness & Performance Expo 2Health News:Health structures explain nearly 20 percent of non-adherence to heart failure guidelines 2Health News:Robert Higgins Named 2015 Best Lawyers® "Lawyer of the Year" in Boston 2Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 2Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 3
... A new decades-long study launches today to investigate whether there ... long-term health problems such as cancer. The cohort study ... and Health Research (MTHR) Programme. The international study will run ... least 250,000 participants aged 18-69 in five European countries. The ...
... led by an Oregon Health & Science University Knight ... be used to help identify physicians who might ... Patricia A. Carney, Ph.D., OHSU School of Medicine professor ... Medicine; and associate director of Cancer Prevention, Control and ...
... ... EcoAdvisor for Earth Day. , ... Midland (PRWEB) April 22, 2010 -- In honour of Earth Day, OnlyGreen has planted 365 ... Mokugift, an official partner of the United Nations Environment Programme,s Plant for the Planet: Billion ...
... far most common choice of discipline , THURSDAY, April 22 ... American parents, but new research suggests it might still be ... conducted for C.S. Mott Children,s Hospital at the University of ... spank their child in some scenarios, said poll director Dr. ...
... ... ... management has come a long way in the last few decades. Advent of modern eye ... , ,We are excited though to tell about the latest technique Dr. Khanna is using ...
... ... LifeLinks innovative Spanish video interpreting services for the price of phone-only interpreting services. ... New York, ... breakthrough Spanish language interpretation. Pay the same for LifeLinks Spanish video interpretation service as ...
Cached Medicine News:Health News:Health impacts of mobile phone use to be explored in huge new study 2Health News:Health impacts of mobile phone use to be explored in huge new study 3Health News:Physicians who interpret mammograms may benefit from additional training 2Health News:Physicians who interpret mammograms may benefit from additional training 3Health News:OnlyGreen Plants 365 Trees for Earth Day 2010 2Health News:One in Five Parents Would Spank in Certain Settings 2Health News:One in Five Parents Would Spank in Certain Settings 3Health News:Glued graft for Pterygium Yield Better Cosmetic Results 2Health News:Glued graft for Pterygium Yield Better Cosmetic Results 3Health News:LifeLinks Revolutionizes Video Interpreting, Shows Spanish Interpreting in Added Dimension-VIDEO! 2
... ANA is an enzyme-linked immunosorbent assay (ELISA) ... (ANA) in human serum. The presence of ... clinical findings and other laboratory tests to ... such as systemic lupus erythematosus, Sjgren's syndrome, ...
The MESACUP ANA Test Kit is a semi-quantitative enzyme-linked immunosorbent assay,(ELISA) for the detection of specific anti-nuclear antibodies in human serum as an aid in,the determination of autoim...
... Immuno Concepts manufactures slides that are compatible ... to decrease the number of pipetting steps ... sample dilutions on the slides. Ask Immuno ... and these slides. These slide formats are ...
... HEp-2 cell line that has been genetically ... autoantibodies, without affecting the other ANA patterns ... worldwide on the HEp-2000 ANA substrate, which ... used in place of standard HEp-2 cells ...
Medicine Products: